Eurofins CDMO
Pharmaceutical Manufacturing • 
Fontenilles, Occitanie, France • 201-500 Employees
Company overview
| Headquarters | 2 bis avenue de Gascogne, Fontenilles, Haute-Garonne 31470, FR |
| Phone number | +33562147314 |
| Website | |
| NAICS | 3254 |
| Keywords | Method Development, API, Quality Control, Analytical Services, Testing, Drug Development, Sterile Manufacturing, Chemistry, Microbiology, R&D, Formulation, Biologics, Bioanalytical, Cdmo, Life Cycle Management, Drug Product, Small Molecules, Cell Banking, Stability Studies, In Life Studies, Fill & Finish, Usp/Dsp, Clinical Packaging And Logistics |
| Founded | 2010 |
| Employees | 201-500 |
| Socials |
Key Contacts at Eurofins CDMO
Claire Dubois Berger
Director Support Services
Dieter Ameye
Director Drug Substance & Drug Product Manufacturing
Rob Jordan
Director, Operations
Christelle Jegou Dujardin
Director Project Management France
Eurofins CDMO Email Formats
Eurofins CDMO uses 3 email formats. The most common is {first name}{last name} (e.g., johndoe@eurofins.com), used 66.4% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@eurofins.com | 66.4% |
{first initial}{last name} | jdoe@eurofins.com | 30.3% |
{2char} | {2char}@eurofins.com | 1.7% |
About Eurofins CDMO
Eurofins CDMO is a leading global Contract Development and Manufacturing Organization (CDMO) that provides clients with APIs / Drug Substance and Drug Product development for biologicals and small molecules. Science is our fondation and allows us to support small and major biopharmaceutical companies. Our sustainable and flexible methods help them achieve their pre-clinical and clinical milestones on time. We are experts in breakthrough technologies for API development, highly potent compounds, poorly soluble drugs, lyophilisation processes and specific therapeutic areas (immunotherapies, orphan drugs, pediatric dosage forms, etc.) Involved in the earliest steps, our highly-qualified project management team will propose a complete drug development strategy in compliance with regulations. Frequent communication through one single point of contact, our team's flexibility, troubleshooting mindset, customized solutions will help speed up the drug development process. Operating under strict quality procedures, Eurofins CDMO is accredited through the FDA, EMA, ANSM, ANSES, FAMHP, PMDA, and Health Canada. Our goal is to build a sustainable partnership with our customers to support their drug development pathway. Our service offerings include: - Drug Substance/API development - Solid State Research & Development - Pre-Formulation, Formulation Development - Analytical Development - GMP Manufacturing - Clinical packaging and logistics - Project management - CMC RA Choose Eurofins CDMO to help you: - Move rapidly through the drug development value chain (API/DS and DP) - Perform complex formulation screening and development - Accelerate process development and scale-up under GMP compliance - Achieve clinical & small commercial manufacturing batches (Sterile and Non Sterile) - Provide clinical trial material including packaging and logistics - Ensure regulatory compliance throughout each stage of the development cycle with full CMC-RA support
Eurofins CDMO revenue & valuation
| Annual revenue | $68,400,000 |
| Revenue per employee | $171,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $218,800,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 201-500
Seniority
Employees
Employees by Department
Eurofins CDMO has 91 employees across 8 departments.
Departments
Number of employees
Funding Data
Eurofins CDMO has never raised funding before.
United States
Azerbaijan
Jordan
Netherlands
Australia
Frequently asked questions
4.8
40,000 users
